Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of Calgary

$17,500.00

Dissecting the central actions of cannabis for treating chronic pain

EF 2021-22

Résumé
Chronic pain is a debilitating medical condition negatively impacting the quality of life of 1 in 5 Canadians, and it is estimated to cost Canadian society an estimated 39 billion dollars annually in healthcare and loss of labour. Neuropathic pain, a subset of chronic pain that is due to damage or disease of the nervous system, is associated with increased pain and disability compared to non-neuropathic chronic pain. In addition, neuropathic pain is often resistant to conventional pain killers like opioids. As such, many pain patients turn to cannabis. However, due to the stigmatized status of cannabis and its associated compounds in many countries around the world, there is little high-quality literature on both the therapeutic and noxious effects of cannabinoids. Since cannabinoids have been legal in Canada since 2018, it is critical to characterize their effects. In my project, I will bridge this gap in the literature by 1) investigating the use of cannabis as an alternative to current treatments for neuropathic pain, and 2) determining the involvement of spinal microgliathe immune cells of the central nervous systemin cannabis-mediated analgesia. Using animal models of nerve pain, I will find the most effective combination of the active ingredients of cannabis for treating pain. Then, I will examine how cannabis acts on the specialized immune cells of the central nervous system, microglia. Microglia are targeted by cannabinoid drugs, and their activation can lead to abnormal pain sensitivity like touch-evoked pain. Using cellular imaging, biochemical and behavioral approaches, I will deconstruct how cannabis modulates the function of microglia in pain. This is essential to determine the effectiveness and improve the safety of cannabis-based pain therapies.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
466816
Name
Davidson Chloé E
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Dissecting the central actions of cannabis for treating chronic pain
Programtype2
Studentship Programs
Orgnameinp2
University of Calgary
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Cannabis; Chronic Nerve Pain; Mechanical Allodynia; Microglia; Pain; Pain Treatment; Pharmacology; Preclinical Health Research; Sex Differences; Spinal Cord
Abstract
Chronic pain is a debilitating medical condition negatively impacting the quality of life of 1 in 5 Canadians, and it is estimated to cost Canadian society an estimated 39 billion dollars annually in healthcare and loss of labour. Neuropathic pain, a subset of chronic pain that is due to damage or disease of the nervous system, is associated with increased pain and disability compared to non-neuropathic chronic pain. In addition, neuropathic pain is often resistant to conventional pain killers like opioids. As such, many pain patients turn to cannabis. However, due to the stigmatized status of cannabis and its associated compounds in many countries around the world, there is little high-quality literature on both the therapeutic and noxious effects of cannabinoids. Since cannabinoids have been legal in Canada since 2018, it is critical to characterize their effects. In my project, I will bridge this gap in the literature by 1) investigating the use of cannabis as an alternative to current treatments for neuropathic pain, and 2) determining the involvement of spinal microgliathe immune cells of the central nervous systemin cannabis-mediated analgesia. Using animal models of nerve pain, I will find the most effective combination of the active ingredients of cannabis for treating pain. Then, I will examine how cannabis acts on the specialized immune cells of the central nervous system, microglia. Microglia are targeted by cannabinoid drugs, and their activation can lead to abnormal pain sensitivity like touch-evoked pain. Using cellular imaging, biochemical and behavioral approaches, I will deconstruct how cannabis modulates the function of microglia in pain. This is essential to determine the effectiveness and improve the safety of cannabis-based pain therapies.
Competitiondate
202112
Approvedterm2
1 yr 0 mth
Pinamesdelim
Davidson, Chloé E
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~